{
  "docId": "019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "docSlug": "61f4be21d1a97a93f2294133e3bf0c0f",
  "documentTitle": "Bausch Health Companies | Investor Conference Presentation Deck | 10 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 10,
  "pageCount": 10,
  "prevPage": 9,
  "nextPage": null,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a grid-based timeline layout to track multiple drug development programs simultaneously.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-ca7e-71d0-9b6d-c6cccc832e2e/10",
  "deckHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e",
  "deckJsonHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e.json",
  "deckAnchorHref": "/decks/019de070-ca7e-71d0-9b6d-c6cccc832e2e#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.82,
        "w": 0.82,
        "x": 0.18,
        "y": 0.06
      },
      "kind": "diagram",
      "text": "Clinical development timeline grid",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84c91e6d-5c4a-4b01-a599-95ecb7598a39",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.18,
        "x": 0.02,
        "y": 0.15
      },
      "kind": "list",
      "text": "Rifaximin solid soluble dispersion (SSD) in a tablet (RED-C); Combination of rifaximin with a mucolytic agent (Irritable Bowel Syndrome - Diarrhea Cedars-Sinai Collaboration); Rifaximin liquid gel capsules (Small Intestinal Bacterial Overgrowth (SIBO)); Rifaximin timed release coated beads in capsules (Sickle Cell Anemia)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adeb49f0-5405-423d-9bbc-849cb291a301",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.25,
        "y": 0.98
      },
      "kind": "source-note",
      "text": "1. See Slide 2 for further information on forward-looking statements.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbfcef2f-acb5-43b8-af46-ec95910db4ed",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "6e47c286-9f79-42cd-827e-04f3eaa1ae82",
      "evidence": "The slide uses a timeline grid to map project milestones over time.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 10,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "7e9449fc-bc2c-49e0-b746-5045ad559669",
      "evidence": "roadmap slide",
      "position": 0,
      "objective": "Why is this important now?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.5,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}